Nightingale Research Logo
ZENITH
ZENITH
Upcoming
-
Adelaide SA

Effect of Zilebesiran in addition to Standard of Care in adults with uncontrolled hypertension and CVD or at risk of CVD.

  • S/C injection every 6 months in clinic
  • Clinic visits every 3 months for the first 12 months
  • After the first year, clinic visits every 6 months
Requirements
  • Age > 18 years
  • Uncontrolled HT
  • Established CVD
  • At risk of CVD